ADA and cancer: Since the ADA is an enzyme involved in autoimmune diseases and cancer development [18,19], it is plausible to hypothesize that the DPP4 involvement in ADA-mediated pathways is at the basis of the elevated sDPP4 levels reported in these diseases [20,21].